Home / Education / Education Courses / LIVE: Psychiatric Disorders in Women: Diagnostic and Treatment Considerations Across the Female Lifespan

LIVE: Psychiatric Disorders in Women: Diagnostic and Treatment Considerations Across the Female Lifespan

Event Date(s): Oct 22, 2020 - 08:00am to Oct 22, 2020 - 03:30pm

This course will focus on the diagnosis and treatment of psychiatric disorders in women across the reproductive lifespan.  Specialized knowledge is necessary to tailor treatments to reproductive events such as pregnancy and pregnancy planning, the postpartum, breastfeeding, the menopausal transition, and menstrual cycle related mood dysregulation.

Available Credits: 6.25 ama 6.25 ancc 6.00 nasw 6.25 participation 6.25 pce Register For This Course

Course Details

Now Virtual!  

This course will focus on the diagnosis and treatment of psychiatric disorders in women across the reproductive lifespan.  Specialized knowledge is necessary to tailor treatments to reproductive events such as pregnancy and pregnancy planning, the postpartum, breastfeeding, the menopausal transition, and menstrual cycle related mood dysregulation.  Exposure to psychotropic medications and the consequence of untreated psychiatric disorders must be considered when treating pregnant women, those who may become pregnant during treatment, and those who are breastfeeding.  Up to date and comprehensive knowledge is required to help patients make collaborative and individualized treatment decisions. Focused material will also be presented regarding the treatment of premenstrual dysphoric disorder and premenstrual mood exacerbation, as well as treatment considerations for the menopausal transition. Learning in this course will be facilitated by didactic materials delivered by the faculty from the MGH Center for Women’s Mental Health.  Faculty will also provide question and answer and case-based discussion sessions for course participants.  Readings to accompany course materials will also be provided.


Registration for this conference is now closed.

Please contact The Psychiatry Academy with any questions at mghcme@mgh.harvard.edu

Pricing

Women’s Mental Health

$250 

Psychopharmacology and Women’s Mental Health Bundled (Savings Of $50)

MDs/Doctoral-Level Professionals 
Early Bird (on or before September 4, 2020) = $849
Regular Registration (after September 4, 2020) = $899

Other Professionals or Trainees 
Early Bird (on or before September 4, 2020) = $609
Regular Registration (after September 4, 2020) = $659


If you are interested in attending Psychiatric Disorders in Women AND the Psychopharmacology conference you can register for all sessions by clicking here.

Syllabus

We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by October 1, 2020.  No refunds will be issued for refund requests made after October 1, 2020. Payments made may not be applied to future conferences or other educational activities.  There are no exceptions to these policies.

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.

Course Summary

Available Credits:6.25 ama 6.25 ancc 6.00 nasw 6.25 participation 6.25 pce
Course Topic:Women's Mental Health, Psychopharmacology
Course Format:Conference / meeting
Target Audience:

This program is intended for:

  • Psychiatrists
  • Psychologists
  • General and Family Practice Physicians
  • Psychiatric Nurses
  • Physician Assistants
  • Nurse Practitioners
  • Social Workers
Event Starts: Oct 22, 2020 - 08:00am
Event Ends: Oct 22, 2020 - 03:30pm
Cost: $250.00

Learning Objectives

Our conference lets you engage dozens of renowned clinician-researchers, get your clinical questions answered, and translate enhanced knowledge into optimal patient care.

Here are some of the ways that participants plan to change their clinical practice as a result of attending our conference:

  • Assess reproductive safety of psychiatric medication during pregnancy
  • Distinguish normal physical, hormonal and emotional changes at menopause from pathophysiologic conditions occurring during the menopausal transition
  • Discuss diagnosis, etiology, and treatment of co-occurring PTSD and SUD in women.
  • Describe best treatment modalities for co-occurring PTSD and SUD in women
  • Describe the pharmacologic and non-pharmacologic treatment options available to their patients with ADHD during pregnancy and lactation
  • Describe the pathophysiology and treatment of PMDD.